U.S Physical Therapy Cost of Goods Sold 2010-2024 | USPH

U.S Physical Therapy cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
U.S Physical Therapy Annual Cost of Goods Sold
(Millions of US $)
2023 $483
2022 $441
2021 $378
2020 $329
2019 $369
2018 $352
2017 $323
2016 $275
2015 $253
2014 $229
2013 $199
2012 $187
2011 $176
2010 $155
2009 $150
U.S Physical Therapy Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $139
2024-06-30 $133
2024-03-31 $127
2023-12-31 $124
2023-09-30 $122
2023-06-30 $119
2023-03-31 $118
2022-12-31 $113
2022-09-30 $113
2022-06-30 $110
2022-03-31 $105
2021-12-31 $103
2021-09-30 $96
2021-06-30 $93
2021-03-31 $86
2020-12-31 $88
2020-09-30 $79
2020-06-30 $65
2020-03-31 $97
2019-12-31 $95
2019-09-30 $90
2019-06-30 $95
2019-03-31 $90
2018-12-31 $92
2018-09-30 $87
2018-06-30 $88
2018-03-31 $85
2017-12-31 $85
2017-09-30 $82
2017-06-30 $80
2017-03-31 $77
2016-12-31 $72
2016-09-30 $69
2016-06-30 $67
2016-03-31 $66
2015-12-31 $65
2015-09-30 $65
2015-06-30 $62
2015-03-31 $60
2014-12-31 $60
2014-09-30 $59
2014-06-30 $56
2014-03-31 $53
2013-12-31 $52
2013-09-30 $50
2013-06-30 $49
2013-03-31 $48
2012-12-31 $47
2012-09-30 $47
2012-06-30 $47
2012-03-31 $46
2011-12-31 $45
2011-09-30 $46
2011-06-30 $43
2011-03-31 $42
2010-12-31 $40
2010-09-30 $39
2010-06-30 $39
2010-03-31 $38
2009-12-31 $38
2009-09-30 $38
2009-06-30 $37
2009-03-31 $36
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.368B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00